drugset / Trial / NCT04884217

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

NCT04884217 ↗

Phase 2 Unknown 80 enrolled PharmaDax Inc. Glia, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and efficacy of 1% Pro-ocular topical gel administered twice daily for 12 weeks in treatment of Dry Eye Disease

Timeline

Start
2021-05-20
Primary completion
2021-10-30
Completion
2021-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pro-ocular™ Unknown 1 % Other

Indications